U.S. Physical Therapy, Inc. (NYSE:USPH) Receives Average Recommendation of "Buy" from Brokerages

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) have been given an average rating of "Buy" by the five analysts that are covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $114.00.

Several equities research analysts recently weighed in on the stock. JMP Securities initiated coverage on shares of U.S. Physical Therapy in a research note on Monday, December 16th. They set an "outperform" rating and a $113.00 target price on the stock. Citizens Jmp raised U.S. Physical Therapy to a "strong-buy" rating in a research report on Monday, December 16th. Barrington Research reiterated an "outperform" rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a report on Thursday, November 21st. JPMorgan Chase & Co. upped their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Tuesday, December 3rd. Finally, Bank of America upgraded U.S. Physical Therapy from a "neutral" rating to a "buy" rating and lifted their price objective for the company from $100.00 to $115.00 in a research note on Monday, December 16th.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the firm's stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the sale, the chief financial officer now owns 20,469 shares of the company's stock, valued at approximately $1,970,141.25. This trade represents a 2.46 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Bernard A. Harris, Jr. sold 2,000 shares of the company's stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total transaction of $185,900.00. Following the completion of the transaction, the director now owns 16,726 shares of the company's stock, valued at approximately $1,554,681.70. The trade was a 10.68 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.70% of the company's stock.

Institutional Investors Weigh In On U.S. Physical Therapy

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Venturi Wealth Management LLC grew its position in shares of U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after acquiring an additional 704 shares during the last quarter. KBC Group NV grew its position in U.S. Physical Therapy by 68.6% during the 3rd quarter. KBC Group NV now owns 774 shares of the company's stock worth $66,000 after purchasing an additional 315 shares during the last quarter. Pacer Advisors Inc. acquired a new position in U.S. Physical Therapy in the fourth quarter valued at $113,000. First Horizon Advisors Inc. raised its holdings in shares of U.S. Physical Therapy by 25.1% in the third quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company's stock valued at $126,000 after buying an additional 298 shares during the last quarter. Finally, International Assets Investment Management LLC boosted its stake in shares of U.S. Physical Therapy by 8,414.8% during the third quarter. International Assets Investment Management LLC now owns 2,299 shares of the company's stock worth $195,000 after buying an additional 2,272 shares during the period.

U.S. Physical Therapy Trading Down 0.9 %

NYSE:USPH traded down $0.76 on Thursday, reaching $86.97. 83,883 shares of the company's stock were exchanged, compared to its average volume of 82,825. The firm has a market capitalization of $1.31 billion, a price-to-earnings ratio of 92.52, a price-to-earnings-growth ratio of 3.61 and a beta of 1.48. U.S. Physical Therapy has a 52-week low of $76.18 and a 52-week high of $113.63. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The business has a fifty day moving average of $91.05 and a 200-day moving average of $88.39.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.